Management of hyperglycemia in minority children with type 2 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 1, 2002, Pages 531-540

  Castells, Salvador ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

CP; C peptide (CP); Diet; Exercise; Group therapy; HbA1c; Insulin pump (CSII); Liquid meal (Sustacal ); Metformin; Minority children (African American); Type 2 diabetes mellitus

Indexed keywords

BIGUANIDE; C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; SUSTACAL; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ABDOMINAL DISCOMFORT; ARTICLE; CELL FUNCTION; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DIET THERAPY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EXERCISE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN PUMP; INSULIN TREATMENT; LIQUID; MALE; MEAL; MINORITY GROUP; NAUSEA; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; ADOLESCENT; CHILD; COMPARATIVE STUDY; DIET; INSULIN DEPENDENT DIABETES MELLITUS; MULTIMODALITY CANCER THERAPY; NUTRITION; REVIEW;

ADOLESCENT; BLOOD GLUCOSE; CHILD; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; DIET; EXERCISE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; NEGROID RACE; NUTRITION; AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; HUMANS; NUTRITION PHYSIOLOGY;

EID: 0036012952     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Biochemical determination of training effects using insulin clamp technique
2. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise
3. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
5. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. UK Prospective Diabetes Study 16: Overview of six years' therapy of type 2 diabetes - A progressive disease
7. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes
8. Starting insulin therapy in patients with type 2 diabetes
9. Randomized trial comparing continuous subcutaneous insulin infusion and conventional therapy in type 2 diabetic patients poorly controlled with sulfonylureas
10. Comprehensive management of type 2 diabetes
11. Insulin resistance, insulin deficiency, and non-insulin dependent diabetes mellitus
12. Near-normoglycemic remission in African-American with type 2 diabetes mellitus associated with recovery of beta cell function
13. Insulin analogues: New agents for improving glycemic control
14. Insulin analogues
15. Long-acting insulin analogs
16. [Lys(B28), Pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin
17. Improved post-prandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function
18. Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin
19. Insulin lispro in CSII: Results of a double-blind crossover study
20. Improved glycemic control with insulin aspart: A multicenter randomized double-blind crossover trial in type 1 diabetic patients
21. Lispro or regular insulin for multiple injection therapy in adolescence: Differences in free insulin and glucose levels overnight
22. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
23. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes
24. Pumps in practice: Practical aspects of continuous subcutaneous insulin infusion (CSII)
25. Long term metabolic control with insulin pump therapy
26. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas
27. Insulin pump therapy: No longer a fad
28. Insulin lispro in CSII: Results of a double-blind crossover study
29. Use of insulin lispro in continuous subcutaneous insulin infusion treatment: Results of a multicenter trial
30. Variability of blood glucose levels in patients treated with continuous subcutaneously infusion: A pilot study
31. Metformin
32. Mechanism of metformin action in obese and lean non-insulin dependent diabetic subjects
33. Metabolic effects of metformin in non-insulin dependent diabetes mellitus
34. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM
35. An overview of metformin in the treatment of type 2 diabetes mellitus
36. Double-blind evaluation of efficacy and tolerability of metformin in NIDDM
37. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
38. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations: A double blind controlled study
39. Efficacy of metformin in patients with non-insulin dependent diabetes mellitus
40. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirements for multiple therapies (UKPDS 49)
41. The combination of insulin and metformin in treatment of non-insulin dependent diabetes mellitus
42. Group therapy in the treatment of diabetes
43. Description of a diabetic support group with lessons for diabetes caregivers
44. Experiences in group discussion with diabetic patients
45. Diabetes mellitus (a psychosomatic study of 147 cases)
46. Group therapy in family practice
47. Group therapy for diabetic mental patients
48. Behavioral analysis and behavioral strategies to improve self-management of type II diabetes
49. Management of obese patients with diabetes mellitus; comparison of advice education with group management